Dissertation > Excellent graduate degree dissertation topics show

MAH Regimen in Treatment of Refractory and Relapsed Acute Myeloid Leukemia

Author: CaiChunXia
Tutor: HuJianDa
School: Fujian Medical
Course: Internal Medicine
Keywords: MAH program Acute myeloid leukemia Refractory Relapse
CLC: R733.7
Type: Master's thesis
Year: 2010
Downloads: 9
Quote: 1
Read: Download Dissertation

Abstract


Objective: To evaluate the MAH programs ( mitoxantrone the cytarabine Homoharringtonine alkali ) treatment of refractory and relapsed acute myeloid leukemia efficacy and safety . : MAH program (mitoxantrone 10 mg qd , continuous intravenous infusion, once every 2 to 3 days ; cytarabine 100mg bid, continuous intravenous infusion , once every 5 to 7 days ; the homoharringtonine base 4 mg qd , intravenous continuous infusion , once every 5 to 7 days ) in the treatment of 37 patients with refractory and relapsed acute myeloid leukemia, refractory the AML15 cases , recurrence AML22 patients . Results: 37 patients with refractory and relapsed AML patients MAH program after 1 to 2 cycles of induction chemotherapy , 15 cases achieved complete remission ( CR ) , CR was 40.5 % ( 15 / 37 ) , of which 14 patients received a courses of induction chemotherapy, patients received two cycles of induction chemotherapy , patients reached partial remission ( PR ) , PR rate was 2.7% ( 1 / 37 ) , with a total effective rate of 43.2% . The median follow-up time was 97 days ( 18 to 487) , median recurrence-free survival time ( RFS ) 147 ( 341 ) days . The main adverse reactions were myelosuppression caused by infection and bleeding . Conclusion : MAH program on the part of refractory and relapsed AML is still valid , the side effects can be tolerated for the treatment of refractory and relapsed AML invalid for other chemotherapy and hematopoietic stem cell transplantation for patients with create opportunities .

Related Dissertations

  1. China Refractory Products Market Marketing Strategy,F274
  2. The Expression of TRPC3 and TRPC6 in the Temporal Cortex from Patients with Intractable Temporal Lobe Epilepsy,R742.1
  3. Detect NPM1 and FLT3-ITD Mutation in Acute Myeloid Leukemia and Assess Its Clinical Significance,R733.71
  4. Rapid, Accurate Detection of TMPRSS6 Gene Mutations with High-resolution Melting Analysis,R346
  5. Research on Pharmaceutical Wastewater Treatment Technologies and Tracing Refractory Pollutants,X703
  6. Based on \,R271.9
  7. Brick Interior Defect Diagnosis Based on Sound,TP274
  8. Study of the Effect of Anti-gastric Ulcer Recurrence and the Mechanism of Anti-inflammation Induced by Puwei Pill,R285.5
  9. The Clinical Significance and Correlation Study of AML1-ETO9a Isoform in AML-M2 with T(8;21),R733.7
  10. The Clinical Observation of Curative Effect Made by Differential Treatment of Refractory Thrombocytopenic Purpura,R259
  11. Study of Risk Factors and Invasion Extention of Recurrent Lingual Carcinoma,R739.8
  12. The Expression of TRPC Channels in the Brain Tissues from Patients with Refractory Temporal Lobe Epilepsy,R742.1
  13. Clinical Analysis on Refractory Malignant Ovarian Germ Cell Tumors,R737.31
  14. Cyclosporine for Refractory Nephritic Syndrome in Adults: A Systematic Review,R692.3
  15. Outcome Analysis of Two Surgical Methods for 24 Cases Giant Cell Tumor of Proximal Femur Bone,R738
  16. The Research of Photocatalytic Degradation of Refractory Organics over Nano-TiO2,X703
  17. Qi stagnation Decoction on multiple sclerosis relapse and cellular immune function in preliminary study,R259
  18. Explorative Study To Identify Novel Candidate Genes Related To Postchemotherapeutic Glioma Relapse Using Oligo Toxicology & Drug Resistance Microarray,R739.41
  19. Clinical Study on Incision at Parts Plana of Ciliary on Refractory Glaucoma Filtering Surgery,R779.6
  20. Clinical Observation of Recurrent Vulvovaginal Candidiasis with Damp-Heat Constitution Treated by QingReZhiDai Decoction,R271.9

CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Leukemia
© 2012 www.DissertationTopic.Net  Mobile